EMD
protein-codingemerin, the group of LEM domain containing
Gene summary
Emerin is a serine-rich nuclear membrane protein and a member of the nuclear lamina-associated protein family. It mediates membrane anchorage to the cytoskeleton. Dreifuss-Emery muscular dystrophy is an X-linked inherited degenerative myopathy resulting from mutation in the emerin gene. [provided by RefSeq, Jul 2008]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~2.3 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: XL
Disease ID:MONDO:0010680
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: XL
Disease ID:MONDO:0000992
Submitter: Genomics England PanelApp
Inheritance Pattern: XL
Disease ID:MONDO:0010680
Submitter: Orphanet
Inheritance Pattern: XLR
Disease ID:MONDO:0010680
Submitter: Natera
Inheritance Pattern: XL
Disease ID:MONDO:0010680
Submitter: Ambry Genetics
Inheritance Pattern: XL
Disease ID:MONDO:0100531
Submitter: PanelApp Australia
Clinical Genomic Database (CGD)
Manifestation: Cardiovascular; Musculoskeletal
Intervention: Cardiovascular
Rationale: Surveillance for and treatment of cardiac disease (eg, with EKG), including pacemaker implantation, may be beneficial
Comments: Individuals, including females, can have serious cardiac conduction defects
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to EMD variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_000117.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 8 | 154 | 1 | 163 | ||
| missense | 2 | 6 | 205 | 38 | 2 | 253 |
| nonsense | 22 | 5 | 1 | 28 | ||
| start loss | 4 | 4 | ||||
| frameshift | 40 | 12 | 2 | 54 | ||
| splice donor/acceptor (+/-2bp) | 9 | 8 | 11 | 28 | ||
| Total | 77 | 31 | 227 | 192 | 3 | 530 |
Highest pathogenic variant AF is 0.000008866506
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_000108.1 | 6 | MANE Select | |
| Ensembl | ENSP00000358857.4 | 6 | MANE Select | |
| Ensembl | ENSP00000358850.3 | 5 | Standard | |
| Ensembl | ENSP00000358850.3 | 5 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Dilated cardiomyopathy (DCM) - Homo sapiens (human)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) - Homo sapiens (human)
- Hypertrophic cardiomyopathy (HCM) - Homo sapiens (human)
- Arrhythmogenic Right Ventricular Cardiomyopathy
- Clearance of Nuclear Envelope Membranes from Chromatin
Biological Process
- muscle contraction
- mitotic nuclear envelope reassembly
- muscle organ development
- skeletal muscle cell differentiation
- positive regulation of protein export from nucleus
Molecular Function
- actin binding
- protein binding
- cadherin binding
- beta-tubulin binding
Cellular Component
- nuclear envelope
- nuclear inner membrane
- nuclear outer membrane
- nucleoplasm
- cytoplasm
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000369842
- Coding exons
- 6
- Length
- 2327
- Individuals with no LoFs
- 0
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 0
- Defined
- 0
- p
- 0.00
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -0.165 | 115 | 110 | 1.04 | 0.00000886 | 1642 |
| Missense (PolyPhen) | 32 | 37.278 | 0.85842 | 558 | ||
| Synonymous | -2.42 | 64 | 43.7 | 1.47 | 0.00000335 | 511 |
| Loss of Function | 2.71 | 0 | 8.55 | 0.00 | 5.43e-7 | 152 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0 | 0.0 | absent |
| South Asian | 0 | 0.0 | absent |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Stabilizes and promotes the formation of a nuclear actin cortical network. Stimulates actin polymerization in vitro by binding and stabilizing the pointed end of growing filaments. Inhibits beta-catenin activity by preventing its accumulation in the nucleus. Acts by influencing the nuclear accumulation of beta- catenin through a CRM1-dependent export pathway. Links centrosomes to the nuclear envelope via a microtubule association. EMD and BAF are cooperative cofactors of HIV-1 infection. Association of EMD with the viral DNA requires the presence of BAF and viral integrase. The association of viral DNA with chromatin requires the presence of BAF and EMD. Required for proper localization of non-farnesylated prelamin-A/C. {ECO:0000269|PubMed:15328537, ECO:0000269|PubMed:16680152, ECO:0000269|PubMed:16858403, ECO:0000269|PubMed:17785515, ECO:0000269|PubMed:19323649}.;
- Disease
- DISEASE: Emery-Dreifuss muscular dystrophy 1, X-linked (EDMD1) [MIM:310300]: A form of Emery-Dreifuss muscular dystrophy, a degenerative myopathy characterized by weakness and atrophy of muscle without involvement of the nervous system, early contractures of the elbows, Achilles tendons and spine, and cardiomyopathy associated with cardiac conduction defects. {ECO:0000269|PubMed:10323252, ECO:0000269|PubMed:11587540, ECO:0000269|PubMed:15009215, ECO:0000269|PubMed:15328537}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.537
Intolerance Scores
- RVIS EVS
- -0.05
- RVIS percentile EVS
- 49.76
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.493
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |